Algiax Pharmaceuticals
PrivateLast Round
VC Round
Dec 9, 2019
Total Funding Raised
$5.53M
Company Overview
Algiax Pharmaceuticals operates in Healthcare & Life Sciences and is based in Dusseldorf. Its latest recorded funding round was a VC Round in December 2019.
Algiax Pharmaceuticals is a clinical-stage biotechnology company that develops innovative small-molecule therapeutics for the treatment of chronic neuropathic pain and other diseases with high unmet medical needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Algiax Pharmaceuticals Comparables
Compare Algiax Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aquilus Pharmaceuticals | 81% | |
| Artelo Biosciences, Inc. | 78% | |
| Dogwood Therapeutics, Inc. | 77% |
For institutional investors. Book with your work email.
Algiax Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 9, 2019 | ||||
| Series A | May 14, 2012 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Algiax Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KfW Development Bank | Series A |
| High-Tech Gründerfonds | Series A |
| OCCIDENT | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 9, 2019
$6.1M round led by OCCIDENT
- May 14, 2012
Raised $5.5M from High-Tech Gründerfonds and KfW.
For institutional investors. Book with your work email.
Algiax Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Algiax Pharmaceuticals's valuation, stock price, and market status.
Is Algiax Pharmaceuticals a public or private company?
Algiax Pharmaceuticals is a private company.
What is the current stock price of Algiax Pharmaceuticals?
Algiax Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Algiax Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Algiax Pharmaceuticals worth (valuation)?
Valuation information for Algiax Pharmaceuticals is not publicly available.
Can I buy Algiax Pharmaceuticals stock?
Algiax Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Algiax Pharmaceuticals's last funding round?
Algiax Pharmaceuticals's most recent funding round was VC Round on December 9, 2019.
Who are the main investors in Algiax Pharmaceuticals?
Key investors in Algiax Pharmaceuticals include KfW Development Bank, High-Tech Gründerfonds, OCCIDENT.
Will Algiax Pharmaceuticals IPO soon?
No public IPO plans have been announced for Algiax Pharmaceuticals.
How can I track Algiax Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Algiax Pharmaceuticals's shares on secondary markets.